ClinConnect ClinConnect Logo
Search / Trial NCT05368038

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · May 9, 2022

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Newborn Screening Rare Diseases Families Genetics Elsi

ClinConnect Summary

Soon after birth, all babies born in the United States have a newborn screening (NBS) test to check for certain medical conditions. All babies are screened, even if they appear healthy, because most of these conditions have no obvious physical findings in a newborn and might otherwise be diagnosed only after the development of serious problems, such as brain damage, organ damage, or death. In fact, NBS has been an integral part of preventable health care for over five decades, ever since the discovery that phenylketonuria is an easily diagnosed, preventable cause of intellectual disability....

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All newborn infants born at a ScreenPlus pilot hospital
  • Infants who are less than four weeks old, regardless of sex, gestational age, or health status.
  • Exclusion Criteria:
  • A newborn screening sample is unavailable
  • Infants who are more than four weeks old

About Albert Einstein College Of Medicine

Albert Einstein College of Medicine is a leading academic institution dedicated to advancing biomedical research and medical education. Situated in the Bronx, New York, it is renowned for its commitment to innovative research and training the next generation of physicians and scientists. The college actively engages in a wide range of clinical trials, focusing on translating scientific discoveries into effective therapies and improving patient care. With a collaborative approach that involves multidisciplinary teams, Albert Einstein College of Medicine aims to address significant health challenges and contribute to the global medical community through rigorous research and evidence-based practices.

Locations

Brooklyn, New York, United States

Manhasset, New York, United States

New York, New York, United States

Stony Brook, New York, United States

New York, New York, United States

Bronx, New York, United States

New York, New York, United States

Brooklyn, New York, United States

Queens, New York, United States

Bronx, New York, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Melissa Wasserstein, MD

Principal Investigator

Albert Einstein College of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials